Barbexaclone
 |
|
| Combination of | |
|---|---|
| Phenobarbital | Barbiturate |
| Levopropylhexedrine | Stimulant (sympathomimetic) |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| ATC code | N03AA04 (WHO) |
| Identifiers | |
| CAS Number |
4388-82-3 
|
| PubChem (CID) | 71196 |
| DrugBank |
DB09001 
|
| ChemSpider |
64332
|
| UNII |
291GX1YB65
|
| ECHA InfoCard | 100.022.278 |
|
(what is this?)
|
|
Barbexaclone (Maliasin) is a salt compound of phenobarbital and levopropylhexedrine. It was introduced in 1983. It has been reported to be as effective as phenobarbital but better tolerated; however, as of 2004, these "promising results" had not yet been confirmed nor denied in controlled trials. 100 mg of barbexaclone is equivalent to 60 mg of phenobarbital.
...
Wikipedia